Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury
- PMID: 35541905
- PMCID: PMC9066113
- DOI: 10.7150/ijbs.69677
Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury
Abstract
Coronavirus disease 2019 (COVID-19), a global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) had resulted in considerable morbidity and mortality. COVID-19 primarily posed a threat to the respiratory system and violated many different organs, including the heart, kidney, liver, and blood vessels with the development of the disease. Severe patients were often accompanied by cardiac injury, and once the heart gets damaged, the mortality of patients will significantly increase. The main clinical manifestations of cardiac injury range from myocarditis, heart failure (HF), arrhythmia, and Takotsubo cardiomyopathy (TCM). A high abundance of angiotensin-converting enzyme II (ACE2) on the membrane of cardiomyocytes makes it possible that the virus can directly attack cardiomyocytes as subsequently evidenced by the detection of spike protein and virus RNA in autopsy cardiac tissues. The secondary myocardial injury through systemic inflammatory and immune response also caused obvious cardiac damage. The pathological manifestations of heart tissue were diverse, varied from mild cardiomyocyte edema, myocardial hypertrophy, cardiomyocyte degeneration, and necrosis to severe myocarditis caused by lymphocyte and macrophage infiltration. However, the mechanism of heart injury was still unclear. Here, we summarized the clinical manifestations and mechanism of SARS-CoV2 mediated cardiac injury, providing a reference for cardiac treatment in critically ill patients.
Keywords: COVID-19; Cardiac injury; Heart; Myocarditis; SARS-CoV2.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
Similar articles
-
Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.J Cell Physiol. 2020 Dec;235(12):9884-9894. doi: 10.1002/jcp.29802. Epub 2020 Jun 8. J Cell Physiol. 2020. PMID: 32510598 Free PMC article.
-
COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?Heart. 2020 Aug;106(15):1127-1131. doi: 10.1136/heartjnl-2020-317186. Epub 2020 Jun 4. Heart. 2020. PMID: 32499236 Review.
-
Wuhan 3 years after the outbreak of the pandemic-cardiological insights and perspectives.Herz. 2023 Jun;48(3):173-179. doi: 10.1007/s00059-023-05176-4. Epub 2023 Apr 27. Herz. 2023. PMID: 37106075 Free PMC article. Review.
-
Clinically Suspected Myocarditis in the Course of Severe Acute Respiratory Syndrome Novel Coronavirus-2 Infection: Fact or Fiction?J Card Fail. 2021 Jan;27(1):92-96. doi: 10.1016/j.cardfail.2020.11.002. Epub 2020 Nov 6. J Card Fail. 2021. PMID: 33166657 Free PMC article. Review.
-
Histologic, viral, and molecular correlates of heart disease in fatal COVID-19.Ann Diagn Pathol. 2022 Oct;60:151983. doi: 10.1016/j.anndiagpath.2022.151983. Epub 2022 May 29. Ann Diagn Pathol. 2022. PMID: 35660807 Free PMC article.
Cited by
-
Myocardial Injuries in COVID-19: More Questions Than Answers.J Clin Med. 2022 Aug 3;11(15):4527. doi: 10.3390/jcm11154527. J Clin Med. 2022. PMID: 35956141 Free PMC article.
-
Decoding HiPSC-CM's Response to SARS-CoV-2: mapping the molecular landscape of cardiac injury.BMC Genomics. 2024 Mar 12;25(1):271. doi: 10.1186/s12864-024-10194-5. BMC Genomics. 2024. PMID: 38475718 Free PMC article.
-
The Potential Mechanisms of Arrhythmia in Coronavirus disease-2019.Int J Med Sci. 2024 May 19;21(7):1366-1377. doi: 10.7150/ijms.94578. eCollection 2024. Int J Med Sci. 2024. PMID: 38818469 Free PMC article. Review.
-
Serial echocardiographic evaluation of COVID-19 patients without prior history of structural heart disease: a 1-year follow-up CRACoV-HHS study.Front Cardiovasc Med. 2023 Sep 13;10:1230669. doi: 10.3389/fcvm.2023.1230669. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37781311 Free PMC article.
-
Cardiac Involvement in COVID-19: A Global Bibliometric and Visualized Analysis.Front Cardiovasc Med. 2022 Jul 27;9:955237. doi: 10.3389/fcvm.2022.955237. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35966543 Free PMC article.
References
-
- Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA cardiology. 2020;5:831–40. - PubMed
-
- Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS. et al. Extrapulmonary manifestations of COVID-19. Nature medicine. 2020;26:1017–32. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous